AAAAAA

   
Results: 1-14 |
Results: 14
MOLECULAR-CLONING AND FUNCTIONAL-CHARACTERIZATION OF THE CDNA-ENCODING THE MURINE THIOPURINE S-METHYLTRANSFERASE (TPMT)
Authors: FESSING MY BELKOV VM KRYNETSKI EY EVANS WE
Citation: My. Fessing et al., MOLECULAR-CLONING AND FUNCTIONAL-CHARACTERIZATION OF THE CDNA-ENCODING THE MURINE THIOPURINE S-METHYLTRANSFERASE (TPMT), FEBS letters, 424(3), 1998, pp. 143-145
FUNCTIONAL-CHARACTERIZATION OF THE HUMAN THIOPURINE S-METHYLTRANSFERASE (TPMT) GENE PROMOTER
Authors: FESSING MY KRYNETSKI EY ZAMBETTI GP EVANS WE
Citation: My. Fessing et al., FUNCTIONAL-CHARACTERIZATION OF THE HUMAN THIOPURINE S-METHYLTRANSFERASE (TPMT) GENE PROMOTER, European journal of biochemistry, 256(3), 1998, pp. 510-517
ISOLATION OF A HUMAN THIOPURINE S-METHYLTRANSFERASE (TPMT) COMPLEMENTARY-DNA WITH A SINGLE NUCLEOTIDE TRANSITION A719G (TPMT-ASTERISK-3C) AND ITS ASSOCIATION WITH LOSS OF TPMT PROTEIN AND CATALYTIC ACTIVITY INHUMANS
Authors: LOENNECHEN T YATES CR FESSING MY RELLING MV KRYNETSKI EY EVANS WE
Citation: T. Loennechen et al., ISOLATION OF A HUMAN THIOPURINE S-METHYLTRANSFERASE (TPMT) COMPLEMENTARY-DNA WITH A SINGLE NUCLEOTIDE TRANSITION A719G (TPMT-ASTERISK-3C) AND ITS ASSOCIATION WITH LOSS OF TPMT PROTEIN AND CATALYTIC ACTIVITY INHUMANS, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 46-51
PHARMACOGENETICS OF CANCER-THERAPY - GETTING PERSONAL
Authors: KRYNETSKI EY EVANS WE
Citation: Ey. Krynetski et We. Evans, PHARMACOGENETICS OF CANCER-THERAPY - GETTING PERSONAL, American journal of human genetics, 63(1), 1998, pp. 11-16
PROMOTER AND INTRONIC SEQUENCES OF THE HUMAN THIOPURINE S-METHYLTRANSFERASE (TPMT) GENE ISOLATED FROM A HUMAN PAC1 GENOMIC LIBRARY
Authors: KRYNETSKI EY FESSING MY YATES CR SUN DX SCHUETZ JD EVANS WE
Citation: Ey. Krynetski et al., PROMOTER AND INTRONIC SEQUENCES OF THE HUMAN THIOPURINE S-METHYLTRANSFERASE (TPMT) GENE ISOLATED FROM A HUMAN PAC1 GENOMIC LIBRARY, Pharmaceutical research, 14(12), 1997, pp. 1672-1678
ENHANCED PROTEOLYSIS OF THIOPURINE S-METHYLTRANSFERASE (TPMT) ENCODEDBY MUTANT ALLELES IN HUMANS (TPMT-ASTERISK-3A, TPMT-ASTERISK-2) - MECHANISMS FOR THE GENETIC-POLYMORPHISM OF TPMT ACTIVITY
Authors: TAI HL KRYNETSKI EY SCHUETZ EG YANISHEVSKI Y EVANS WE
Citation: Hl. Tai et al., ENHANCED PROTEOLYSIS OF THIOPURINE S-METHYLTRANSFERASE (TPMT) ENCODEDBY MUTANT ALLELES IN HUMANS (TPMT-ASTERISK-3A, TPMT-ASTERISK-2) - MECHANISMS FOR THE GENETIC-POLYMORPHISM OF TPMT ACTIVITY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(12), 1997, pp. 6444-6449
MOLECULAR DIAGNOSIS OF THIOPURINE S-METHYLTRANSFERASE DEFICIENCY - RESPONSE
Authors: KRYNETSKI EY EVANS WE
Citation: Ey. Krynetski et We. Evans, MOLECULAR DIAGNOSIS OF THIOPURINE S-METHYLTRANSFERASE DEFICIENCY - RESPONSE, Annals of internal medicine, 127(11), 1997, pp. 1041-1042
MOLECULAR DIAGNOSIS OF THIOPURINE S-METHYLTRANSFERASE DEFICIENCY - GENETIC-BASIS FOR AZATHIOPRINE AND MERCAPTOPURINE INTOLERANCE
Authors: YATES CR KRYNETSKI EY LOENNECHEN T FESSING MY TAI HL PUI CH RELLING MV EVANS WE
Citation: Cr. Yates et al., MOLECULAR DIAGNOSIS OF THIOPURINE S-METHYLTRANSFERASE DEFICIENCY - GENETIC-BASIS FOR AZATHIOPRINE AND MERCAPTOPURINE INTOLERANCE, Annals of internal medicine, 126(8), 1997, pp. 608
GENETIC-POLYMORPHISM OF THIOPURINE S-METHYLTRANSFERASE - CLINICAL IMPORTANCE AND MOLECULAR MECHANISMS
Authors: KRYNETSKI EY TAI HL YATES CR FESSING MY LOENNECHEN T SCHUETZ JD RELLING MV EVANS WE
Citation: Ey. Krynetski et al., GENETIC-POLYMORPHISM OF THIOPURINE S-METHYLTRANSFERASE - CLINICAL IMPORTANCE AND MOLECULAR MECHANISMS, Pharmacogenetics, 6(4), 1996, pp. 279-290
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY - 2 NUCLEOTIDE TRANSITIONS DEFINE THE MOST PREVALENT MUTANT ALLELE ASSOCIATED WITH LOSS OF CATALYTIC ACTIVITY IN CAUCASIANS
Authors: TAI HL KRYNETSKI EY YATES CR LOENNECHEN T FESSING MY KRYNETSKAIA NF EVANS WE
Citation: Hl. Tai et al., THIOPURINE S-METHYLTRANSFERASE DEFICIENCY - 2 NUCLEOTIDE TRANSITIONS DEFINE THE MOST PREVALENT MUTANT ALLELE ASSOCIATED WITH LOSS OF CATALYTIC ACTIVITY IN CAUCASIANS, American journal of human genetics, 58(4), 1996, pp. 694-702
HIGHER ACTIVITY OF POLYMORPHIC THIOPURINE S-METHYLTRANSFERASE IN ERYTHROCYTES FROM NEONATES COMPARED TO ADULTS
Authors: MCLEOD HL KRYNETSKI EY WILIMAS JA EVANS WE
Citation: Hl. Mcleod et al., HIGHER ACTIVITY OF POLYMORPHIC THIOPURINE S-METHYLTRANSFERASE IN ERYTHROCYTES FROM NEONATES COMPARED TO ADULTS, Pharmacogenetics, 5(5), 1995, pp. 281-286
HIGH-YIELD EXPRESSION OF FUNCTIONALLY ACTIVE HUMAN LIVER CYP2D6 IN YEAST-CELLS
Authors: KRYNETSKI EY DRUTSA VL KOVALEVA IE LUZIKOV VN
Citation: Ey. Krynetski et al., HIGH-YIELD EXPRESSION OF FUNCTIONALLY ACTIVE HUMAN LIVER CYP2D6 IN YEAST-CELLS, Pharmacogenetics, 5(2), 1995, pp. 103-109
A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE
Authors: KRYNETSKI EY SCHUETZ JD GALPIN AJ PUI CH RELLING MV EVANS WE
Citation: Ey. Krynetski et al., A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(4), 1995, pp. 949-953
METHYLATION OF MERCAPTOPURINE, THIOGUANINE, AND THEIR NUCLEOTIDE METABOLITES BY HETEROLOGOUSLY EXPRESSED HUMAN THIOPURINE S-METHYLTRANSFERASE
Authors: KRYNETSKI EY KRYNETSKAIA NF YANISHEVSKI Y EVANS WE
Citation: Ey. Krynetski et al., METHYLATION OF MERCAPTOPURINE, THIOGUANINE, AND THEIR NUCLEOTIDE METABOLITES BY HETEROLOGOUSLY EXPRESSED HUMAN THIOPURINE S-METHYLTRANSFERASE, Molecular pharmacology, 47(6), 1995, pp. 1141-1147
Risultati: 1-14 |